The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Protocols: The Essential Handbook for Regeneration and Health: BPC157 Peptides: Lyman, Dan: 9798309682713: Amazon.com: Books NDI warning letters fuel criticism of FDA enforcement approach FDA Moves to Reevaluate Several Peptides American Med Spa Association FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures